Drug Information

Drug General Information
Drug ID
D02DUO
Former ID
DNC003605
Drug Name
KYS-05001
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529044]
Structure
Download
2D MOL

3D MOL
Formula
C28H30N4O
Canonical SMILES
C1CCN(CC1)C2=NC3=CC=CC=C3C(N2C4=CC=CC=C4)CC(=O)NCC5=CC=<br />CC=C5
InChI
1S/C28H30N4O/c33-27(29-21-22-12-4-1-5-13-22)20-26-24-16-8-9-17-25(24)30-28(31-18-10-3-11-19-31)32(26)23-14-6-2-7-15-23/h1-2,4-9,12-17,26H,3,10-11,18-21H2,(H,29,33)
InChIKey
IROXHJVGJHVBSD-UHFFFAOYSA-N
PubChem Compound ID
9980573
Target and Pathway
Target(s) Voltage-dependent T-type calcium channel subunit alpha-1H Target Info Inhibitor [527099]
Voltage-dependent T-type calcium channel alpha-1G subunit Target Info Inhibitor [529044]
KEGG Pathway MAPK signaling pathway
Calcium signaling pathway
Circadian entrainmenthsa04010:MAPK signaling pathway
Circadian entrainment
Type II diabetes mellitus
PANTHER Pathway Endogenous cannabinoid signaling
GABA-B receptor II signaling
Nicotine pharmacodynamics pathway
Pathway Interaction Database Regulation of nuclear beta catenin signaling and target gene transcription
PathWhiz Pathway Muscle/Heart ContractionPW000564:Muscle/Heart Contraction
Reactome NCAM1 interactionsR-HSA-419037:NCAM1 interactions
WikiPathways Corticotropin-releasing hormone
NCAM signaling for neurite out-growthWP1866:NCAM signaling for neurite out-growth
Nicotine Activity on Chromaffin Cells
References
Ref 529044Bioorg Med Chem Lett. 2007 Nov 1;17(21):5740-3. Epub 2007 Sep 1.Discovery of potent T-type calcium channel blocker.
Ref 527099Bioorg Med Chem Lett. 2004 Jul 5;14(13):3379-84.3,4-Dihydroquinazoline derivatives as novel selective T-type Ca2+ channel blockers.
Ref 529044Bioorg Med Chem Lett. 2007 Nov 1;17(21):5740-3. Epub 2007 Sep 1.Discovery of potent T-type calcium channel blocker.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.